
Please try another search
Anatara Lifesciences Ltd engages in the research, development, and commercialization of evidence-based solutions for gastrointestinal diseases in animals and humans in Australia. The company offers Gastrointestinal ReProgramming, a proprietary formulation to address irritable bowel syndrome. It also provides Detach for the treatment of diarrhea disease in piglets. Anatara Lifesciences Ltd was incorporated in 2010 and is based in Adelaide, Australia.
Name | Age | Since | Title |
---|---|---|---|
Rebecca Burgell | - | 2018 | Member of Product Development Advisory Board |
Barry Campbell | - | 2018 | Member of Product Development Advisory Board |
Jakob Begun | - | 2018 | Member of Product Development Advisory Board |
Simon Keely | - | 2018 | Member of Product Development Advisory Board |
John Michailidis | - | 2022 | COO & Executive Director |
Jonathan Lindh | - | 2024 | Company Secretary & Non-Executive Director |
Peter Gibson | - | 2018 | Chairman of Product Development Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review